Strata Mental Health Solutions Awarded U.S. Healthcare Provider Training Grant from Compass Pathways to Develop Provider Training for COMP360
Compass Pathways awarded one of its five U.S. health care provider training grants to Strata Mental Health Solutions, a private training and implementation partner, to develop provider training for COMP360, Compass' investigational psilocybin treatment. The grant supports commercial readiness ahead of a potential approval: Compass has reported positive results from two Phase 3 trials, expects to complete its NDA submission in the fourth quarter of 2026 under a rolling FDA pathway, and targets a commercial launch in the first half of 2027.
Key figures
- Drug Name
- COMP360
- Phase Of Trial
- Phase 3
- Hcp training grants
- 5
- Nda submission timing
- Q4 2026
- Expected commercial launch
- first half of 2027
- Phase3 trials reported positive
- 2
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.